Incorporating Genomic Information in the Treatment of MDS

Explore the latest advancements in incorporating genomic information for treating Myelodysplastic Syndrome (MDS) through this keynote presentation from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delivered by Guillermo Garcia-Manero and introduced by Rashmi Kanagal-Shamanna, this hour-long talk delves into cutting-edge approaches for leveraging genomic data to improve MDS patient care. Gain insights into how clinical cytogeneticists, molecular geneticists, and molecular pathologists are working together to enhance cancer diagnosis and treatment strategies. Learn about the CGC's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic-based diagnoses for all cancer patients to guide optimal therapy selection.